SSRI use during acute COVID-19 and risk of Long COVID among patients with depression

Abstract Background Long COVID, also known as post-acute sequelae of COVID-19 (PASC), is a poorly understood condition with symptoms across a range of biological domains that often have debilitating consequences. Some have recently suggested that lingering SARS-CoV-2 virus particles in the gut may i...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	BMC Medicine
المؤلفون الرئيسيون:	Zachary Butzin-Dozier, Yunwen Ji, Sarang Deshpande, Eric Hurwitz, A. Jerrod Anzalone, Jeremy Coyle, Junming Shi, Andrew Mertens, Mark J. van der Laan, John M. Colford, Rena C. Patel, Alan E. Hubbard, the National COVID Cohort Collaborative (N3C) Consortium
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	BMC 2024-10-01
الموضوعات:	COVID-19 Long COVID SSRI
الوصول للمادة أونلاين:	https://doi.org/10.1186/s12916-024-03655-x